Meyer RG - Search Results

1

Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.

Distler E, Schnürer E, Wagner E, von Auer C, Plachter B, Wehler D, Huber C, Kolbe K, Meyer RG, Herr W. Distler E, et al. Among authors: meyer rg. Biol Blood Marrow Transplant. 2008 Dec;14(12):1417-24. doi: 10.1016/j.bbmt.2008.09.004. Biol Blood Marrow Transplant. 2008. PMID: 19041065 Free article.

2

Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes.

Hartwig UF, Nonn M, Khan S, Meyer RG, Huber C, Herr W. Hartwig UF, et al. Among authors: meyer rg. Bone Marrow Transplant. 2006 Feb;37(3):297-305. doi: 10.1038/sj.bmt.1705238. Bone Marrow Transplant. 2006. PMID: 16327814

3

Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation.

Meyer RG, Wagner EM, Konur A, Bender K, Schmitt T, Hemmerling J, Wehler D, Hartwig UF, Roosnek E, Huber C, Kolbe K, Herr W. Meyer RG, et al. Bone Marrow Transplant. 2010 Apr;45(4):668-74. doi: 10.1038/bmt.2009.212. Epub 2009 Aug 17. Bone Marrow Transplant. 2010. PMID: 19684624

4

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation.

Meyer RG, Britten CM, Wehler D, Bender K, Hess G, Konur A, Hartwig UF, Wehler TC, Ullmann AJ, Gentilini C, Uharek L, Huber C, Kolbe K, Herr W. Meyer RG, et al. Blood. 2007 Jan 1;109(1):374-82. doi: 10.1182/blood-2006-03-005769. Epub 2006 Aug 29. Blood. 2007. PMID: 16940425 Free article. Clinical Trial.

5

Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation.

Kleemann P, Distler E, Wagner EM, Thomas S, Klobuch S, Aue S, Schnürer E, Schild H, Theobald M, Plachter B, Tenzer S, Meyer RG, Herr W. Kleemann P, et al. Among authors: meyer rg. Haematologica. 2012 Jun;97(6):874-82. doi: 10.3324/haematol.2011.052597. Epub 2011 Dec 29. Haematologica. 2012. PMID: 22207687 Free PMC article.

6

Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation.

Penack O, Fischer L, Stroux A, Gentilini C, Nogai A, Muessig A, Rieger K, Ganepola S, Herr W, Meyer RG, Thiel E, Uharek L. Penack O, et al. Among authors: meyer rg. Bone Marrow Transplant. 2008 Feb;41(4):377-83. doi: 10.1038/sj.bmt.1705911. Epub 2007 Nov 5. Bone Marrow Transplant. 2008. PMID: 17982494

7

The programmed death (PD)-1/PD-ligand 1 pathway regulates graft-versus-host-reactive CD8 T cells after liver transplantation.

Schuchmann M, Meyer RG, Distler E, von Stebut E, Kuball J, Schnürer E, Wölfel T, Theobald M, Konur A, Gregor S, Schreiner O, Huber C, Galle PR, Otto G, Herr W. Schuchmann M, et al. Among authors: meyer rg. Am J Transplant. 2008 Nov;8(11):2434-44. doi: 10.1111/j.1600-6143.2008.02401.x. Am J Transplant. 2008. PMID: 18925909 Free article.

8

Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality.

Hartwig UF, Winkelmann N, Wehler T, Kreiter S, Schneider PM, Meyer RG, Ullmann AJ, Huber C, Kolbe K, Herr W. Hartwig UF, et al. Among authors: meyer rg. Ann Hematol. 2005 May;84(5):331-8. doi: 10.1007/s00277-004-1001-5. Epub 2005 Feb 23. Ann Hematol. 2005. PMID: 15726363

9

Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines.

Wehler TC, Nonn M, Brandt B, Britten CM, Gröne M, Todorova M, Link I, Khan SA, Meyer RG, Huber C, Hartwig UF, Herr W. Wehler TC, et al. Among authors: meyer rg. Blood. 2007 Jan 1;109(1):365-73. doi: 10.1182/blood-2006-04-014100. Epub 2006 Aug 24. Blood. 2007. PMID: 16931626 Free article.

10

Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.

Distler E, Wölfel C, Köhler S, Nonn M, Kaus N, Schnürer E, Meyer RG, Wehler TC, Huber C, Wölfel T, Hartwig UF, Herr W. Distler E, et al. Among authors: meyer rg. Exp Hematol. 2008 Apr;36(4):451-63. doi: 10.1016/j.exphem.2007.12.011. Epub 2008 Feb 8. Exp Hematol. 2008. PMID: 18261837 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters